VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 97 filers reported holding VERONA PHARMA PLC in Q1 2023. The put-call ratio across all filers is 1.24 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,210,062 | -23.3% | 221,996 | -14.7% | 0.02% | -25.0% |
| Q1 2024 | $4,186,618 | -30.3% | 260,200 | -13.8% | 0.03% | -30.0% |
| Q4 2023 | $6,003,760 | +93.4% | 302,000 | +58.6% | 0.04% | +66.7% |
| Q3 2023 | $3,103,617 | -23.9% | 190,406 | -1.3% | 0.02% | -31.4% |
| Q2 2023 | $4,078,265 | -39.5% | 192,917 | -42.5% | 0.04% | -46.2% |
| Q1 2023 | $6,740,856 | -38.5% | 335,700 | -20.0% | 0.06% | -28.6% |
| Q4 2022 | $10,969,296 | +1719.1% | 419,797 | +611.5% | 0.09% | +1720.0% |
| Q3 2022 | $603,000 | +165.6% | 59,000 | +8.7% | 0.01% | +150.0% |
| Q2 2022 | $227,000 | -22.3% | 54,300 | -7.0% | 0.00% | -33.3% |
| Q1 2022 | $292,000 | -25.1% | 58,400 | +0.7% | 0.00% | -25.0% |
| Q4 2021 | $390,000 | +21.5% | 58,000 | -1.0% | 0.00% | +33.3% |
| Q3 2021 | $321,000 | -15.7% | 58,600 | +0.7% | 0.00% | -25.0% |
| Q2 2021 | $381,000 | -19.3% | 58,200 | +3.0% | 0.00% | -33.3% |
| Q1 2021 | $472,000 | +41.3% | 56,500 | +18.2% | 0.01% | +50.0% |
| Q4 2020 | $334,000 | -1.8% | 47,800 | -12.5% | 0.00% | -33.3% |
| Q3 2020 | $340,000 | – | 54,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 2,369,000 | $47,095,720 | 7.54% |
| NEA Management Company, LLC | 5,108,563 | $111,024,890 | 7.40% |
| Vivo Capital, LLC | 4,249,918 | $84,488,370 | 6.92% |
| Aisling Capital Management LP | 1,115,352 | $22,173,198 | 6.61% |
| Rosalind Advisors, Inc. | 250,000 | $4,970,000 | 4.09% |
| First Turn Management, LLC | 1,206,291 | $23,981,065 | 3.44% |
| Knoll Capital Management, LLC | 200,000 | $3,976,000 | 3.29% |
| Frazier Life Sciences Management, L.P. | 3,014,349 | $59,925,258 | 3.20% |
| Tri Locum Partners LP | 293,112 | $5,827,067 | 2.66% |
| Carlyle Group Inc. | 2,457,500 | $48,805,950 | 2.35% |